Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX
Clinical trial NCT06353581 · UNKNOWN
Trial details
- NCT number
- NCT06353581
- Sponsor
- Yonsei University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-16
- Primary completion
- 2024-05-08
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.